Neoadjuvant chemotherapy fails to improve survival in advanced ovarian cancer: but is it the real culprit?

Int J Gynecol Cancer. 2011 May;21(4):596. doi: 10.1097/IGC.0b013e318214d4af.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Ovarian Epithelial
  • Combined Modality Therapy
  • Disease Progression
  • Female
  • Gynecologic Surgical Procedures
  • Humans
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Neoplasms, Glandular and Epithelial / diagnosis
  • Neoplasms, Glandular and Epithelial / drug therapy*
  • Neoplasms, Glandular and Epithelial / mortality*
  • Neoplasms, Glandular and Epithelial / pathology
  • Ovarian Neoplasms / diagnosis
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / mortality*
  • Ovarian Neoplasms / pathology
  • Prognosis
  • Survival Analysis
  • Treatment Failure